Esophageal schwannoma is a rare benign submucosal tumor originating from Schwann cells of the peripheral nerve sheath. Only 2% of all GI schwannomas occur in the esophagus, usually localized in the distal third. It originates from vagus nerve branches or esophageal nerve plexus. It is a slow-growing, encapsulated tumor with very rare malignant transformation (less than 1%). It gives similar submucosal mass findings to leiomyoma and GIST on imaging, but marked T2 hyperintensity on MRI (Antoni B myxoid stroma) and capsule presence are distinguishing. S-100 positive, c-KIT negative, SMA negative on immunohistochemistry (leiomyoma is SMA positive, GIST is c-KIT positive). May be associated with NF2 syndrome. Treatment is surgical resection for large or symptomatic lesions; small asymptomatic lesions may be observed.
Age Range
30-70
Peak Age
50
Gender
Female predominant
Prevalence
Rare
Schwannoma is a benign neoplastic proliferation of Schwann cells of peripheral nerves. In the esophagus, it originates from vagus nerve branches or esophageal myenteric nerve plexus (Auerbach's plexus) — growing within muscularis propria. Histologically, it contains two distinct components: Antoni A areas (compact, organized spindle cells — forming Verocay bodies with nuclear palisading) and Antoni B areas (loose myxoid stroma, disorganized cells, extracellular matrix rich in free water). The high free water content of Antoni B areas produces bright signal on T2 MRI — the most valuable finding for distinguishing from leiomyoma (compact smooth muscle fibers, short T2 relaxation time, low signal). Schwannoma is encapsulated (capsule derived from perineurium) and pushes but does not invade surrounding tissues — well-defined appearance on CT and MRI reflects this capsule. In large tumors, cystic degeneration may develop as Antoni B areas become dominant. Peripheral lymphoid cuff (lymphoid tissue accumulation around schwannoma) is specific to GI schwannomas and is more prominent in gastric schwannomas. On DWI, schwannoma generally shows free diffusion (high ADC) — this feature helps differentiate from malignant peripheral nerve sheath tumor (MPNST).
Pattern of peripheral hyperintense ring (Antoni B myxoid stroma) with central low signal area (Antoni A compact cells) on MRI T2. Directly reflects schwannoma's histological dual-component structure. This pattern is specific to nerve sheath tumors and has high specificity for differentiation from other submucosal tumors (leiomyoma, GIST).
Markedly hyperintense, well-defined encapsulated submucosal mass on T2-weighted sequence. Antoni B myxoid stroma areas show very bright (near-fluid) T2 signal. In large tumors, 'target sign' may be seen — peripheral T2 hyperintense ring (Antoni B) with central lower signal area (Antoni A). Capsule may be visible as thin low T2 signal line. This T2 hyperintensity pattern is the most critical finding for differentiation from leiomyoma.
Report Sentence
Markedly hyperintense signal on T2 with thin hypointense capsule in the esophageal submucosal mass, consistent with schwannoma; target sign pattern present.
Well-defined, round-oval, homogeneously enhancing submucosal mass on CT. Capsule may sometimes be visible as thin low-density ring. Enhancement is homogeneous or with slight peripheral predominance — different from GIST's heterogeneous enhancement. Necrosis is rare (reflects benign character). In large schwannomas, cystic degeneration (Antoni B dominance) may be seen as low-density areas. The mass may show exophytic growth toward the mediastinum.
Report Sentence
Well-defined, encapsulated, homogeneously enhancing submucosal mass measuring approximately ___ cm in the esophageal wall; consistent with schwannoma.
Schwannoma generally does not show marked diffusion restriction on DWI — ADC values are high (generally >1.5 × 10⁻³ mm²/s). This finding reflects the benign schwannoma's loose cellular structure and wide extracellular space. MPNST (malignant peripheral nerve sheath tumor) shows marked diffusion restriction with low ADC — this difference is critical for benign-malignant differentiation. Cystic degeneration areas show very high ADC values.
Report Sentence
No marked diffusion restriction on DWI in the esophageal submucosal mass with high ADC values (___ × 10⁻³ mm²/s); consistent with benign schwannoma.
Well-defined, encapsulated, homogeneously hypoechoic mass connected to muscularis propria (4th layer) on EUS. Schwannoma gives similar appearance to leiomyoma and GIST on EUS — all three originate from 4th layer. Internal echo structure in schwannoma is usually homogeneous, necrosis or cystic areas are rare (in small tumors). Capsule may sometimes be visible as thin hyperechoic ring. EUS-guided fine needle aspiration (FNA) may be used for diagnosis but is often insufficient — core biopsy or excisional biopsy may be needed.
Report Sentence
Well-defined, encapsulated hypoechoic submucosal mass showing continuity with muscularis propria (4th layer) on EUS; consistent with schwannoma.
Schwannoma shows iso- or slightly hypointense signal relative to muscle on T1-weighted sequence. Capsule may be visible as thin low-signal ring. On contrast-enhanced T1, it shows homogeneous and moderate-to-intense enhancement — peripheral enhancement predominance may be present. Cystic degeneration areas show low T1 signal and absence of enhancement. Gadolinium-enhanced MRI clearly separates solid and cystic components of the tumor.
Report Sentence
Isointense signal to muscle on T1 and homogeneous enhancement on contrast-enhanced sequence in the esophageal submucosal mass with thin capsule; consistent with schwannoma.
Well-defined, homogeneous soft tissue density submucosal mass on non-contrast CT (generally 30-50 HU). Calcification is rare. Cystic degeneration areas may have low density. Mass is sharply demarcated from surrounding structures — reflects capsule. Non-contrast CT alone does not differentiate schwannoma-leiomyoma-GIST; contrast-enhanced examination and MRI are required.
Report Sentence
Well-defined, homogeneous soft tissue density submucosal mass in the esophageal wall on non-contrast CT; characterization with contrast-enhanced examination and MRI recommended.
Criteria
Contains both histological components. Most common type. Antoni A areas (compact, Verocay bodies) and Antoni B areas (loose myxoid stroma) coexist.
Distinct Features
Target sign on MRI. Heterogeneous hyperintensity on T2 (mixture of A and B areas). Homogeneous enhancement. Capsule prominent. S-100 positive.
Criteria
Antoni A areas dominant (>90%). More cellular, mitotic activity may be increased. Can be confused with MPNST.
Distinct Features
Lower signal on MR T2 (less myxoid stroma). Mild diffusion restriction on DWI may be present (different from conventional). More intense enhancement on CT. Target sign may not be seen. Capsule intact. Differentiated from MPNST by immunohistochemistry.
Criteria
Antoni B areas dominant. Cystic degeneration and myxoid change prominent. More common in large, long-standing tumors.
Distinct Features
Very prominent hyperintensity on MR T2 (near-fluid). Cystic areas do not enhance. Free diffusion on DWI (very high ADC). Low density areas on CT. Can be confused with duplication cyst — but wall thickness and enhancement pattern allow differentiation.
Distinguishing Feature
Leiomyoma shows low signal on T2 (smooth muscle fibers — short T2); schwannoma is markedly hyperintense on T2 (myxoid stroma — long T2). Both originate from 4th layer and appear similar on EUS. Leiomyoma is SMA positive/S-100 negative; schwannoma is S-100 positive/SMA negative. Leiomyoma may not show capsule; schwannoma is encapsulated.
Distinguishing Feature
GIST may show heterogeneous enhancement and necrosis; schwannoma enhances homogeneously and necrosis is rare. Both can be T2 hyperintense but target sign and capsule are more prominent in schwannoma. GIST is c-KIT positive/S-100 negative; schwannoma is S-100 positive/c-KIT negative. GIST has malignancy potential; schwannoma is benign.
Distinguishing Feature
Granular cell tumor is usually smaller (<2 cm) and originates from submucosa/muscularis mucosae (layers 2-3); schwannoma originates from 4th layer. Granular cell tumor shows low-to-intermediate T2 signal; schwannoma is markedly hyperintense. Both are S-100 positive but histologically very different.
Distinguishing Feature
Duplication cyst is entirely cystic and does not enhance (0-20 HU); schwannoma is solid mass and enhances. Duplication cyst is very hyperintense on T2 (fluid signal), low on T1; schwannoma is T2 hyperintense but solid components enhance. Duplication cyst is congenital; schwannoma is acquired neoplasm.
Urgency
routineManagement
surgicalBiopsy
NeededFollow-up
6-monthEsophageal schwannoma is a benign tumor and malignant transformation is very rare. Small (<2 cm) and asymptomatic lesions can be monitored with EUS at 6-12 month intervals. Surgical resection (enucleation or segmental resection) is recommended for large or symptomatic lesions. EUS-guided FNA or core biopsy is performed for diagnostic confirmation — immunohistochemistry (S-100 positive, c-KIT negative, SMA negative, desmin negative) differentiates schwannoma from leiomyoma and GIST. Genetic evaluation is recommended if NF2 syndrome is suspected. Endoscopic submucosal dissection (ESD) or endoscopic enucleation is a minimally invasive alternative in suitable cases. Recurrence after complete resection is very rare.
Esophageal schwannomas are benign with very low risk of malignant transformation. Surgical enucleation or resection is performed for symptomatic lesions. Follow-up is sufficient for small asymptomatic lesions.